Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

LyondellBasell (LYB)

NYSE: LYB · Specialty Chemicals · Houston, TX

Our rating: Cautious

Cautious reaffirmed at $60.72, moderate conviction, November 6, 2026.

Breaks if: The cautious view proves wrong if LYB reports trailing-twelve-month free cash flow above $1.5B in either of the next two quarterly filings, confirming the gap between accounting income and actual cash has begun to close as the cycle turns. On price, a move above $78 — roughly 28% above today's level — sustained for 63 trading days would signal the market is pricing in a recovery not yet visible in the reported figures, and the call would need to be revisited.

Key figures

Market value$18.0B
Revenue, last 12 months$32.0B
Net income, last 12 months$1.3B
Free cash flow, last 12 months$2.4B
Price to earnings13.9×
Free cash flow yield13.4%
Dividend yield6.2%
Operating margin8.6%
Return on equity11.9%
Beta to the S&P 5000.61
Volatility, annualized38.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$8.5B10.0%$2.32$1.4B
June 30, 2026$9.2B19.8%$1.71$482M
March 31, 2026$7.2B−6.3%$0.38−$538M
December 31, 2025$7.1B−9.2%$-0.45$1.1B
September 30, 2025$7.7B−10.2%$-2.77$577M
June 30, 2025$7.7B−11.8%$0.34−$188M
March 31, 2025$7.7B−7.6%$0.54−$1.1B
December 31, 2024$7.8B261.8%$-1.85$1.4B

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

15 ledger entries and 52 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.